Cambrex Corp (NYSE:CBM)
CAPS Rating:
A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.
Investors Writing for Investors
A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Caps Most upCategory Personal ScoreGrowth Rates % Very LowPrice Ratios HighProfit Margins % HighFinancial Condition HighInvestment Returns % HighManagement Efficiency HighTotal Score Very Low